Yüklüyor......
The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
We retrospectively reviewed outcomes of treatments with cisplatin and topotecan in patients with previously-treated uterine cervix cancer. We analyzed the medical records of patients with advanced (stage IVB) or recurrent or persistent squamous or non-squamous cell carcinoma of the cervix, who were...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5902288/ https://ncbi.nlm.nih.gov/pubmed/29620661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000010340 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|